The HIV-1 Vpr displays strong anti-apoptotic activity

FEBS Lett. 1998 Jul 31;432(1-2):17-20. doi: 10.1016/s0014-5793(98)00824-2.

Abstract

Mutations in the human immunodeficiency virus type 1 (HIV-1) vpr gene only slightly reduce the replication rate of the virus. To study the role of HIV-1 Vpr in biological effects on cells, HEp-2 cells, which express HIV-1 Vpr constitutively but at a low level, were established. While control HEp-2 cells underwent apoptosis when incubated with sorbitol, the morphological and biochemical apoptotic changes were inefficiently induced in the HIV-1 Vpr-expressing cells by the same treatment. These results clearly indicate that HIV-1 Vpr has anti-apoptotic activity, and raise the possibility that Vpr acts as a weak activator of virus replication through anti-apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • COS Cells
  • Gene Products, vpr / genetics
  • Gene Products, vpr / pharmacology*
  • HIV-1*
  • Humans
  • Recombinant Proteins / pharmacology
  • Transformation, Genetic
  • Tumor Cells, Cultured
  • vpr Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, vpr
  • Recombinant Proteins
  • vpr Gene Products, Human Immunodeficiency Virus